Insulin receptor (basal) drugs for Type 2 Diabetes
13 tracked Insulin receptor (basal) drugs in the Type 2 Diabetes race. The class explanation lives on the Insulin receptor (basal) page; the full indication pipeline across every mechanism is on the Type 2 Diabetes page.
7 approved / phase 44 Phase 31 Phase 21 Phase 1
Head-to-head evidence: GZR101 vs GZR33 · GZR101 vs IcoSema · GZR101 vs Insulin Efsitora Alfa · GZR101 vs Insulin glargine (Basaglar) · GZR101 vs Insulin glargine (Toujeo) · GZR101 vs Insulin sudelidec (INS068)